Medtronic, Inc. (MDT) PT Lowered to $98 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Evercore ISI Removes Medtronic, Inc. (MDT) from TAP List
May 21, 2025 4:52 PM EDTEvercore ISI analyst Vijay Kumar reiterated an Outperform rating and $103.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Heading into earnings, we had TAP (tactical, actionable, positioning) calls on A, DHR, ENOV, MDT, SYK, TMO, & RVTY (previous tap note... More
Medtronic (MDT) to separate Diabetes business
May 21, 2025 7:49 AM EDTMedtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes business into a new standalone company ("New Diabetes Company"). This strategic decision for both Medtronic and New Diabetes Company will create a more focused Medtronic, with a more simplified portfolio in high margin growth markets. At the same time, it will create an independent, scaled leader in Diabetes, focused on accelerating innovation and differentiated as the only company to commercialize a complete ecosystem to address... More
JPMorgan Reiterates Neutral Rating on Medtronic, Inc. (MDT)
May 21, 2025 7:21 AM EDTJPMorgan analyst Robbie Marcus reiterated a Neutral rating and $95.00 price target on Medtronic, Inc. (NYSE: MDT)
The analyst comments "This morning Medtronic reported that it will spin off its diabetes business within the next 18 months, ideally in a two-part transaction with an initial IPO of... More
Medtronic (MDT) Raises Quarterly Dividend 1.4% to $0.71; 3.3% Yield, 48th consecutive year of an increase in the dividend payment
May 21, 2025 7:00 AM EDTMedtronic (NYSE: MDT) declared a quarterly dividend of $0.71 per share, or $2.84 annualized. This is a 1.4% increase from the prior dividend of $0.70.
The dividend will be payable on June 11, 2025, to stockholders of record on June 27, 2025, with an ex-dividend date of June 26,... More
Medtronic (MDT) Tops Q4 EPS by 4c; guides below
May 21, 2025 6:47 AM EDTMedtronic (NYSE: MDT) reported Q4 EPS of $1.62, $0.04 better than the analyst estimate of $1.58. Revenue for the quarter came in at $8.93 billion versus the consensus estimate of $8.82 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.50-$5.60, versus the consensus of $5.83. The... More
Medtronic to separate diabetes business following recent struggles
May 21, 2025 5:18 AM EDTBy Kamal Choudhury and Puyaan Singh
(Reuters) -Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps and other wearable devices, into a stand-alone company and forecast 2026 adjusted profit below estimates.
The unit has been struggling over the last few years following regulatory concerns over quality management and cybersecurity issues related to its certain devices. But it has since returned to growth.
"It's ready to be a standalone company," Medtronic CEO Geoff Martha told Reuters in an interview.... More
Medtronic (MDT) to Separate Diabetes Business - WSJ
May 21, 2025 5:10 AM EDTMedtronic (NYSE: MDT) to Separate Diabetes Business - WSJ
source: https://www.wsj.com/business/medtronic-diabetes-company-fe0aeb3f... MoreMedtronic (MDT) to Separate Diabetes Business as Stand-Alone Company -- WSJ
May 21, 2025 5:07 AM EDTMedtronic (MDT) to Separate Diabetes Business as Stand-Alone Company -- WSJ
... MoreMedtronic (MDT) May 23 weekly option implied volatility elevated into quarter results
May 20, 2025 9:55 AM EDTMedtronic (NYSE: MDT) May 23 weekly call option implied volatility is at 55, June is at 25; compared to its 52-week range of 14 to 44 into the expected release of quarter results before the bell on May 21.
... MoreMedtronic (MDT) call put ratio 1 call to 3.1 puts into quarter results
May 20, 2025 6:03 AM EDTMedtronic (NYSE: MDT) May 23 weekly 87 straddle priced for movement of 4% into the expected release of quarter results before the bell on May 21.
... MoreNeedham Reiterates Hold Rating on Medtronic, Inc. (MDT) ahead of earnings
May 19, 2025 7:05 AM EDTNeedham analyst Michael Matson reiterated a Hold rating on Medtronic, Inc. (NYSE: MDT).
The analyst comments "Medtronic will report its F4Q25 earnings on Wednesday, 5/21/25 at 6:45 am ET and host its earnings webcast at 8:00 am ET. Inside this note, we provide a preview of... More
